KAHR Medical's Series A - III Round

KAHR Medical raised a round of funding on September 10, 2013.

KAHR Medical is an Israeli biotech company developing a drug platform known as DSP (Dual Signaling Proteins), bi-functional fusion proteins that are based on the TNF-superfamily, the proteins that con…

Articles about KAHR Medical's Series A - III Round: